print button


With philanthropic support, our biomedical researchers will continue contributing to the world’s fight against cancer.

Designer Drugs
We are engaged in cutting-edge experimental therapeutics—an effort to design novel medications tailored to individual patients.

Earliest Detection
Our researchers are developing biomarkers—molecular fingerprints—to detect cancer at its earliest stages without surgery or biopsy.

We are investigating nanoscale therapies to precisely deliver targeted treatments to tumors while preserving healthy tissues.

Gene Therapy
Our expert team is developing gene therapies to undermine cancer with personalized treatments and targeted strikes on cancer cells.

Make a Gift

Marc Friedman, MD

Marc Friedman, MD, performs chemoembolization on a patient with liver cancer.

Support Cedars-Sinai